Ezharmia Tablet Post-marketing Surveillance
Recruiting
- Conditions
- peripheral T-cell lymphoma: (PTCL)
- Registration Number
- jRCT2031240338
- Lead Sponsor
- Daiichi Sankyo Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
All patients who start receiving Ezharmia Tablet during the registration period.
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative incidence of AEs safety specifications : myelosuppression, infection and the secondary malignancy of the survey
- Secondary Outcome Measures
Name Time Method